BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29531545)

  • 1. Differentiating and Categorizing of Liposarcoma and Synovial Sarcoma Neoplasms by Fluorescence in Situ Hybridization.
    Shahi F; Alishahi R; Pashaiefar H; Jahanzad I; Kamalian N; Ghavamzadeh A; Yaghmaie M
    Iran J Pathol; 2017; 12(3):209-217. PubMed ID: 29531545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
    Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A
    Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Value of MDM2 and DDIT3 Fluorescence In Situ Hybridization in Liposarcoma Classification: A Single-Institution Experience.
    Cho J; Lee SE; Choi YL
    Korean J Pathol; 2012 Apr; 46(2):115-22. PubMed ID: 23109990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
    Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Classic and Molecular Cytogenetic Alterations in Soft-Tissue Sarcomas: Analysis of 46 Tumors With Emphasis on Adipocytic Tumors and Synovial Sarcoma.
    Rao UN; Cieply K; Sherer C; Surti U; Gollin SM
    Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):168-177. PubMed ID: 26808135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
    Binh MB; Sastre-Garau X; Guillou L; de Pinieux G; Terrier P; Lagacé R; Aurias A; Hostein I; Coindre JM
    Am J Surg Pathol; 2005 Oct; 29(10):1340-7. PubMed ID: 16160477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas.
    Song MJ; Cho KJ; Lee JS; Song JS
    Appl Immunohistochem Mol Morphol; 2017; 25(10):712-719. PubMed ID: 27028243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silver In Situ Hybridization for the Rapid Assessment of MDM2 Amplification in Soft Tissue and Bone Tumors. Validation Based on an Audit of 192 Consecutive Cases Evaluated by Silver In Situ Hybridization and Fluorescence In Situ Hybridization.
    Farshid G; Otto S; Collis M; Napper S; Nicola M
    Appl Immunohistochem Mol Morphol; 2023 Feb; 31(2):101-106. PubMed ID: 36692149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal translocations in human soft tissue sarcomas by interphase fluorescence in situ hybridization.
    Yoshida H; Nagao K; Ito H; Yamamoto K; Ushigome S
    Pathol Int; 1997 Apr; 47(4):222-9. PubMed ID: 9103213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
    Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
    Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
    Kammerer-Jacquet SF; Thierry S; Cabillic F; Lannes M; Burtin F; Henno S; Dugay F; Bouzillé G; Rioux-Leclercq N; Belaud-Rotureau MA; Stock N
    Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report.
    Grifasi C; Calogero A; Carlomagno N; Campione S; D'Armiento FP; Renda A
    World J Surg Oncol; 2013 Nov; 11():305. PubMed ID: 24279301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence in situ analysis of soft tissue tumor associated genetic alterations in formalin-fixed paraffin-embedded tissue.
    Horn H; Allmanritter J; Doglioni C; Marx A; Müller J; Gattenlöhner S; Staiger AM; Rosenwald A; Ott G; Ott MM
    Pathol Res Pract; 2014 Dec; 210(12):804-11. PubMed ID: 25446247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
    Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
    Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities.
    Noujaim J; Jones RL; Swansbury J; Gonzalez D; Benson C; Judson I; Fisher C; Thway K
    Br J Cancer; 2017 Feb; 116(5):669-678. PubMed ID: 28141799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocations and amplifications of chromosome 12 in liposarcoma demonstrated by the LSI CHOP breakapart rearrangement probe.
    Willmore-Payne C; Holden J; Turner KC; Proia A; Layfield LJ
    Arch Pathol Lab Med; 2008 Jun; 132(6):952-7. PubMed ID: 18517278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanished MDM2 amplification in multiple recurrences of an irradiated poorly differentiated sarcoma with amplified TRIO::TERT fusion gene.
    Goffinet S; Di Mauro I; Doyen J; Boyer J; Birtwisle-Peyrottes I; Keslair F; Pedeutour F; Dadone-Montaudie B
    Genes Chromosomes Cancer; 2023 Jun; 62(6):342-352. PubMed ID: 36916207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors.
    Miura Y; Keira Y; Ogino J; Nakanishi K; Noguchi H; Inoue T; Hasegawa T
    Pathol Int; 2012 Jan; 62(1):16-27. PubMed ID: 22192800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomas.
    Zhang W; McElhinny A; Nielsen A; Wang M; Miller M; Singh S; Rueger R; Rubin BP; Wang Z; Tubbs RR; Nagle RB; Roche P; Wu P; Pestic-Dragovich L
    Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):54-61. PubMed ID: 20881839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic value of SYT-SSX fusion gene detection by fluorescence in-situ hybridization for synovial sarcoma].
    Sun Y; Sun BC; Liu YX; Zhang SW; Zhao XL; Wang J; Hao XS
    Zhonghua Bing Li Xue Za Zhi; 2008 Oct; 37(10):660-4. PubMed ID: 19094483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.